MICOS10
geneOn this page
Also known as RP5-1056L3.2FLJ36999MIO10Mic10
Summary
MICOS10 (mitochondrial contact site and cristae organizing system subunit 10, HGNC:32068) is a protein-coding gene on chromosome 1p36.13, encoding MICOS complex subunit MIC10 (Q5TGZ0). Component of the MICOS complex, a large protein complex of the mitochondrial inner membrane that plays crucial roles in the maintenance of crista junctions, inner membrane architecture, and formation of contact sites to the outer membrane. It is a selective cancer dependency (DepMap: 49.3% of cell lines).
Involved in cristae formation. Located in mitochondrion. Part of MIB complex; MICOS complex; and SAM complex.
Source: NCBI Gene 440574 — RefSeq curated summary.
At a glance
- GWAS associations: 11
- Clinical variants (ClinVar): 22 total
- Druggable target: yes
- Cancer dependency (DepMap): dependent in 49.3% of screened cell lines
- MANE Select transcript:
NM_001032363
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32068 |
| Approved symbol | MICOS10 |
| Name | mitochondrial contact site and cristae organizing system subunit 10 |
| Location | 1p36.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | RP5-1056L3.2, FLJ36999, MIO10, Mic10 |
| Ensembl gene | ENSG00000173436 |
| Ensembl biotype | protein_coding |
| OMIM | 616574 |
| Entrez | 440574 |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 8 protein_coding_CDS_not_defined, 6 protein_coding
ENST00000322753, ENST00000462646, ENST00000467029, ENST00000479642, ENST00000481464, ENST00000485362, ENST00000486890, ENST00000498067, ENST00000498642, ENST00000617872, ENST00000648702, ENST00000917696, ENST00000917697, ENST00000917698
RefSeq mRNA: 3 — MANE Select: NM_001032363
NM_001032363, NM_001204082, NM_001204083
CCDS: CCDS30620, CCDS72719
Canonical transcript exons
ENST00000322753 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001465875 | 19626387 | 19629820 |
| ENSE00001841013 | 19596979 | 19597109 |
| ENSE00003582626 | 19623474 | 19623583 |
| ENSE00003619534 | 19622100 | 19622147 |
Expression profiles
Bgee: expression breadth ubiquitous, 214 present calls, max score 99.20.
FANTOM5 (CAGE): breadth broad, TPM avg 0.9895 / max 87.4256, expressed in 188 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 1066 | 63.3860 | 1826 |
| 1067 | 0.8926 | 162 |
| 1068 | 0.0863 | 26 |
| 1064 | 0.0106 | 4 |
Top tissues by expression
248 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 99.20 | gold quality |
| apex of heart | UBERON:0002098 | 99.12 | gold quality |
| right atrium auricular region | UBERON:0006631 | 99.03 | gold quality |
| lower esophagus | UBERON:0013473 | 99.00 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 99.00 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 98.90 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 98.89 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 98.88 | gold quality |
| transverse colon | UBERON:0001157 | 98.82 | gold quality |
| right frontal lobe | UBERON:0002810 | 98.72 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 98.70 | gold quality |
| rectum | UBERON:0001052 | 98.64 | gold quality |
| colonic epithelium | UBERON:0000397 | 98.62 | gold quality |
| metanephros cortex | UBERON:0010533 | 98.55 | gold quality |
| body of stomach | UBERON:0001161 | 98.50 | gold quality |
| adenohypophysis | UBERON:0002196 | 98.49 | gold quality |
| endocervix | UBERON:0000458 | 98.42 | gold quality |
| ectocervix | UBERON:0012249 | 98.40 | gold quality |
| popliteal artery | UBERON:0002250 | 98.34 | gold quality |
| tibial artery | UBERON:0007610 | 98.34 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 98.32 | gold quality |
| right adrenal gland | UBERON:0001233 | 98.26 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 98.24 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 98.24 | gold quality |
| left coronary artery | UBERON:0001626 | 98.21 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 98.16 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 98.16 | gold quality |
| ascending aorta | UBERON:0001496 | 98.15 | gold quality |
| left adrenal gland | UBERON:0001234 | 98.14 | gold quality |
| thoracic aorta | UBERON:0001515 | 98.13 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-11 | yes | 8.36 |
| E-GEOD-124858 | no | 260.11 |
| E-MTAB-7606 | no | 133.96 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
75 targeting MICOS10, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-499A-5P | 99.98 | 70.79 | 1323 |
| HSA-MIR-3605-5P | 99.96 | 67.12 | 932 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-576-5P | 99.84 | 70.46 | 2582 |
| HSA-MIR-4668-5P | 99.79 | 70.58 | 3782 |
| HSA-MIR-4422 | 99.72 | 72.07 | 2908 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-1200 | 99.71 | 70.42 | 1838 |
| HSA-MIR-3714 | 99.71 | 70.74 | 2671 |
| HSA-MIR-29B-2-5P | 99.67 | 68.98 | 1726 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-378A-5P | 99.65 | 66.33 | 1311 |
| HSA-MIR-586 | 99.65 | 70.40 | 2051 |
| HSA-MIR-7156-5P | 99.64 | 68.81 | 1369 |
| HSA-MIR-1252-3P | 99.55 | 67.71 | 2862 |
| HSA-MIR-7853-5P | 99.54 | 69.30 | 2055 |
| HSA-MIR-105-5P | 99.54 | 69.24 | 2060 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 49.3% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 5)
- Proteomic analyses reveal MINOS1/Mio10 as a novel constituent of Mitofilin/Fcj1 complexes in human and yeast mitochondria (PMID:22114354)
- APOOL is a cardiolipin-binding component of the Mitofilin/MINOS protein complex. (PMID:23704930)
- Listeria monocytogenes Exploits Mitochondrial Contact Site and Cristae Organizing System Complex Subunit Mic10 To Promote Mitochondrial Fragmentation and Cellular Infection. (PMID:32019800)
- Multicolor 3D MINFLUX nanoscopy of mitochondrial MICOS proteins. (PMID:32788360)
- Conserved GxxxG and WN motifs of MIC13 are essential for bridging two MICOS subcomplexes. (PMID:34271005)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Micos10 | ENSMUSG00000050608 |
| rattus_norvegicus | Micos10 | ENSRNOG00000089574 |
Protein
Protein identifiers
MICOS complex subunit MIC10 — Q5TGZ0 (reviewed: Q5TGZ0)
Alternative names: Mitochondrial inner membrane organizing system protein 1
All UniProt accessions (3): Q5TGZ0, A0A087WU07, A0A3B3IRY5
UniProt curated annotations — full annotation on UniProt →
Function. Component of the MICOS complex, a large protein complex of the mitochondrial inner membrane that plays crucial roles in the maintenance of crista junctions, inner membrane architecture, and formation of contact sites to the outer membrane.
Subunit / interactions. Component of the mitochondrial contact site and cristae organizing system (MICOS) complex, composed of at least MICOS10/MIC10, CHCHD3/MIC19, CHCHD6/MIC25, APOOL/MIC27, IMMT/MIC60, APOO/MIC23/MIC26 and MICOS13/MIC13. This complex was also known under the names MINOS or MitOS complex. The MICOS complex associates with mitochondrial outer membrane proteins SAMM50, MTX1 and MTX2 (together described as components of the mitochondrial outer membrane sorting assembly machinery (SAM) complex) and DNAJC11, mitochondrial inner membrane protein TMEM11 and with HSPA9. The MICOS and SAM complexes together with DNAJC11 are part of a large protein complex spanning both membranes termed the mitochondrial intermembrane space bridging (MIB) complex. Interacts with IMMT/MIC60 and MICOS13/MIC13. Interacts with APOO/MIC23/MIC26 and APOOL/MIC27. Interacts with ARMC1.
Subcellular location. Mitochondrion inner membrane.
Similarity. Belongs to the MICOS complex subunit Mic10 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5TGZ0-1 | 1 | yes |
| Q5TGZ0-2 | 2 |
RefSeq proteins (3): NP_001027535, NP_001191011, NP_001191012 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007512 | Mic10 | Family |
Pfam: PF04418
UniProt features (7 total): splice variant 2, initiator methionine 1, chain 1, transmembrane region 1, topological domain 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5TGZ0-F1 | 72.13 | 0.00 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 2
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-8949613 | Cristae formation |
| R-HSA-1592230 | Mitochondrial biogenesis |
| R-HSA-1852241 | Organelle biogenesis and maintenance |
MSigDB gene sets: 141 (showing top):
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, GOBP_CRISTAE_FORMATION, GOBP_INNER_MITOCHONDRIAL_MEMBRANE_ORGANIZATION, GOCC_MITOCHONDRIAL_ENVELOPE, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, GOBP_MEMBRANE_ORGANIZATION, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP, GOCC_ORGANELLE_MEMBRANE_CONTACT_SITE, GOCC_OUTER_MITOCHONDRIAL_MEMBRANE_PROTEIN_COMPLEX, GOCC_ORGANELLE_INNER_MEMBRANE, GOCC_INNER_MITOCHONDRIAL_MEMBRANE_PROTEIN_COMPLEX, GOCC_MEMBRANE_PROTEIN_COMPLEX, GOCC_MITOCHONDRIAL_PROTEIN_CONTAINING_COMPLEX, RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN
GO Biological Process (2): inner mitochondrial membrane organization (GO:0007007), cristae formation (GO:0042407)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (7): SAM complex (GO:0001401), mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial crista junction (GO:0044284), MICOS complex (GO:0061617), MIB complex (GO:0140275), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Mitochondrial biogenesis | 1 |
| Organelle biogenesis and maintenance | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| inner mitochondrial membrane protein complex | 2 |
| mitochondrial membrane organization | 1 |
| inner mitochondrial membrane organization | 1 |
| binding | 1 |
| mitochondrial outer membrane translocase complex | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| mitochondrial inner membrane | 1 |
| organelle membrane contact site | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1030 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MICOS10 | CHCHD3 | Q9NX63 | 994 |
| MICOS10 | CHCHD6 | Q9BRQ6 | 982 |
| MICOS10 | IMMT | Q16891 | 975 |
| MICOS10 | APOOL | Q6UXV4 | 965 |
| MICOS10 | APOO | Q9BUR5 | 939 |
| MICOS10 | MICOS13 | Q5XKP0 | 912 |
| MICOS10 | SAMM50 | Q9Y512 | 766 |
| MICOS10 | MTX1 | Q13505 | 697 |
| MICOS10 | MTX2 | O75431 | 667 |
| MICOS10 | DNAJC11 | Q9NVH1 | 629 |
| MICOS10 | ELOF1 | P60002 | 587 |
| MICOS10 | CHCHD10 | Q8WYQ3 | 574 |
| MICOS10 | MRPL48 | Q96GC5 | 543 |
| MICOS10 | ZNF780A | O75290 | 513 |
| MICOS10 | GUK1 | Q16774 | 490 |
IntAct
12 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MICOS10 | APOC4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MPC2 | MICOS10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| APOC4 | MICOS10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MICOS10 | CIDEB | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC6A3 | GET1 | psi-mi:“MI:0914”(association) | 0.350 |
| SVOP | PGRMC1 | psi-mi:“MI:0914”(association) | 0.350 |
| MICOS10 | MPC2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MICOS10 | CIDEB | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (92): MINOS1 (Affinity Capture-RNA), MINOS1 (Affinity Capture-RNA), MINOS1 (Affinity Capture-MS), MINOS1 (Affinity Capture-RNA), MINOS1 (Affinity Capture-RNA), MINOS1 (Affinity Capture-RNA), MINOS1 (Negative Genetic), MINOS1 (Negative Genetic), MINOS1 (Positive Genetic), MINOS1 (Positive Genetic), MINOS1 (Positive Genetic), MINOS1 (Positive Genetic), MINOS1 (Negative Genetic), MINOS1 (Negative Genetic), MINOS1 (Negative Genetic)
ESM2 similar proteins: A0A1D8PI78, A1XQR6, A2RVP7, A4QNF3, B2RYW8, O44477, O48528, P0CR88, P0CR89, P25710, P32897, P60602, P60603, P63030, P63031, P79082, P87130, P87146, Q02889, Q12328, Q3SZV8, Q3ZCG2, Q4V7T9, Q54K35, Q54QM0, Q55GU4, Q5NVQ1, Q5TGZ0, Q6BT35, Q6BZY4, Q6CRJ6, Q6FT37, Q6NYD1, Q751T2, Q75E80, Q7KSC4, Q7TNS2, Q80W89, Q8HXG6, Q8IN78
Diamond homologs: B2RYW8, Q5TGZ0, Q751T2, Q7RYI0, Q7TNS2, Q8LAJ9, Q96VH5, Q9HFF0, Q9N4K0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
22 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 20 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1206 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:19597105:GATAG:G | donor_gain | 1.0000 |
| 1:19597106:A:G | donor_gain | 1.0000 |
| 1:19597106:ATAGG:A | donor_loss | 1.0000 |
| 1:19597108:AGGT:A | donor_loss | 1.0000 |
| 1:19597109:GGTAA:G | donor_loss | 1.0000 |
| 1:19597110:GTAAG:G | donor_loss | 1.0000 |
| 1:19597111:T:A | donor_loss | 1.0000 |
| 1:19622148:G:GG | donor_gain | 1.0000 |
| 1:19626474:GGA:G | donor_gain | 1.0000 |
| 1:19626475:GAG:G | donor_gain | 1.0000 |
| 1:19626477:G:GG | donor_gain | 1.0000 |
| 1:19597069:G:GT | donor_gain | 0.9900 |
| 1:19597110:G:GG | donor_gain | 0.9900 |
| 1:19623579:TCA:T | donor_gain | 0.9900 |
| 1:19623584:G:GG | donor_gain | 0.9900 |
| 1:19626474:G:GT | donor_gain | 0.9900 |
| 1:19626475:GA:G | donor_gain | 0.9900 |
| 1:19485430:CTTTA:C | donor_loss | 0.9800 |
| 1:19485431:TTTA:T | donor_loss | 0.9800 |
| 1:19485432:TTA:T | donor_loss | 0.9800 |
| 1:19485433:TACCA:T | donor_loss | 0.9800 |
| 1:19485434:A:AC | donor_gain | 0.9800 |
| 1:19485435:C:CC | donor_gain | 0.9800 |
| 1:19597924:TC:T | donor_gain | 0.9800 |
| 1:19626464:G:GT | donor_gain | 0.9800 |
| 1:19626509:A:AG | donor_gain | 0.9800 |
| 1:19626510:G:GG | donor_gain | 0.9800 |
| 1:19626513:A:AG | donor_gain | 0.9800 |
| 1:19626457:G:GT | donor_gain | 0.9700 |
| 1:19626498:ACAAT:A | donor_gain | 0.9700 |
AlphaMissense
501 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:19622124:T:A | V30D | 0.997 |
| 1:19597082:T:C | C13R | 0.996 |
| 1:19622100:G:A | G22D | 0.996 |
| 1:19623504:G:A | G48D | 0.996 |
| 1:19623534:G:A | C58Y | 0.996 |
| 1:19597109:G:C | G22R | 0.995 |
| 1:19622111:G:A | G26R | 0.995 |
| 1:19622111:G:C | G26R | 0.995 |
| 1:19622112:G:A | G26E | 0.995 |
| 1:19622117:G:A | G28R | 0.995 |
| 1:19622117:G:C | G28R | 0.995 |
| 1:19622118:G:A | G28E | 0.995 |
| 1:19623482:T:A | W41R | 0.995 |
| 1:19623482:T:C | W41R | 0.995 |
| 1:19623516:G:A | G52E | 0.995 |
| 1:19623533:T:A | C58S | 0.995 |
| 1:19623533:T:C | C58R | 0.995 |
| 1:19623534:G:C | C58S | 0.995 |
| 1:19597084:T:G | C13W | 0.994 |
| 1:19597083:G:A | C13Y | 0.993 |
| 1:19623498:G:A | G46D | 0.993 |
| 1:19623535:T:G | C58W | 0.993 |
| 1:19622106:G:A | G24D | 0.992 |
| 1:19623509:G:A | G50R | 0.992 |
| 1:19623509:G:C | G50R | 0.992 |
| 1:19623515:G:A | G52R | 0.991 |
| 1:19623515:G:C | G52R | 0.991 |
| 1:19597082:T:A | C13S | 0.990 |
| 1:19597083:G:C | C13S | 0.990 |
| 1:19622105:G:C | G24R | 0.990 |
dbSNP variants (sampled 300 via entrez): RS1000068305 (1:19595625 A>G), RS1000116952 (1:19596053 T>C), RS1000170163 (1:19603599 T>A), RS1000280616 (1:19597670 C>G,T), RS1000492563 (1:19621320 A>C,G), RS1000552537 (1:19596305 T>C), RS1000563156 (1:19602682 A>G,T), RS1000669162 (1:19596824 G>A), RS1000884736 (1:19621058 C>G,T), RS1000982177 (1:19614438 C>G,T), RS1001114677 (1:19602566 A>G), RS1001128239 (1:19608416 A>C,G,T), RS1001463754 (1:19615090 T>C), RS1001554026 (1:19598687 C>T), RS1001606671 (1:19626326 T>C)
Disease associations
OMIM: gene MIM:616574 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
11 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002458_2 | Serum thyroid-stimulating hormone levels | 3.000000e-07 |
| GCST003988_22 | Hypothyroidism | 8.000000e-09 |
| GCST006309_2 | Post bronchodilator percent predicted FEV1 in smoking | 9.000000e-06 |
| GCST010696_18 | Cortical thickness (min-P) | 1.000000e-10 |
| GCST010697_49 | Cortical surface area (min-P) | 9.000000e-13 |
| GCST010698_58 | Subcortical volume (min-P) | 9.000000e-10 |
| GCST010699_28 | Brain morphology (min-P) | 3.000000e-09 |
| GCST010700_3 | Cortical thickness (MOSTest) | 2.000000e-20 |
| GCST010701_23 | Cortical surface area (MOSTest) | 2.000000e-44 |
| GCST010702_68 | Subcortical volume (MOSTest) | 2.000000e-11 |
| GCST010703_80 | Brain morphology (MOSTest) | 3.000000e-16 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004314 | forced expiratory volume |
| EFO:0004346 | neuroimaging measurement |
| EFO:0004840 | cortical thickness |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4105956 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression | 4 |
| Benzo(a)pyrene | increases expression | 3 |
| bisphenol A | increases abundance, decreases expression, affects cotreatment, affects expression | 2 |
| ginger extract | affects cotreatment, affects expression, increases abundance | 1 |
| dicrotophos | decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| sodium arsenite | increases expression | 1 |
| K 7174 | decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Calcitriol | increases expression, affects cotreatment | 1 |
| Doxorubicin | decreases expression | 1 |
| Oils, Volatile | affects expression, increases abundance, affects cotreatment | 1 |
| Smoke | decreases expression | 1 |
| Dihydrotestosterone | increases expression | 1 |
| Testosterone | affects cotreatment, increases expression | 1 |
| Urethane | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4012556 | Binding | Binding affinity to MICOS complex subunit MIC10 in human INA-6 cells after 3 hrs by nanoLC-MS/MS method | Ugi Reaction-Derived α-Acyl Aminocarboxamides Bind to Phosphatidylinositol 3-Kinase-Related Kinases, Inhibit HSF1-Dependent Heat Shock Response, and Induce Apoptosis in Multiple Myeloma Cells. — J Med Chem |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_SY39 | HAP1 MINOS1 (-) | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): hypothyroidism